Yue Zhou1,2,3†
Chengzhi Huang
Xueqing Yao
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
- 2Department of Gastrointestinal Surgery, Ganzhou Municipal Hospital, Ganzhou, China
- 3Department of Gastrointestinal Surgery, Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
- 4Department of Gastrointestinal and Anorectal Surgery, The First People’s Hospital of Zhaoqing, Zhaoqing, China
- 5School of Medicine, South China University of Technology, Guangzhou, China
A Corrigendum on:
Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
By Zhou Y, Zhang Q, Wang M, Huang C and Yao X (2022). Front. Oncol. 12:827891. doi: 10.3389/fonc.2022.827891
In the original article, there was a mistake in Figure 3 as published. While preparing the figures, the labels of the bar charts in Figure 3 were misspelled. The corrected Figure 3 appears below.
FIGURE 3
Figure 3 Knockdown of ATP7A expression may inhibit cancer tumorigenesis in vitro (A) Colony formation assays in HCT116 and LOVO cells. (B) A flow cytometer was performed to assess the apoptosis rate of HCT116 and LOVO cells. (C) Wound healing assay of HCT116 and LOVO cells. (D) Transwell assay was performed to evaluate the invasion of HCT116 and LOVO cells. **P < 0.01 and ***P < 0.001 when compared to the control group.
In the published article, there was also an error in affiliation 3. Instead of “Department of Gastrointestinal Surgery, Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China”, it should be “Department of Gastrointestinal Surgery, Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China”.
There was a further error as an affiliation was omitted for authors Minjia Wang, Chengzhi Huang and Xueqing Yao. These authors should also have affiliation 5 – “School of Medicine, South China University of Technology, Guangzhou, China”.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: oxaliplatin, chemoresistance, siRNA delivery, colorectal cancer, ATP7A
Citation: Zhou Y, Zhang Q, Wang M, Huang C and Yao X (2022) Corrigendum: Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer. Front. Oncol. 12:916983. doi: 10.3389/fonc.2022.916983
Received: 10 April 2022; Accepted: 09 May 2022;
Published: 27 June 2022.
Edited and reviewed by:
Zeming Liu, Huazhong University of Science and Technology, ChinaCopyright © 2022 Zhou, Zhang, Wang, Huang and Yao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xueqing Yao, c3l5YW94dWVxaW5nQHNjdXQuZWR1LmNu; Chengzhi Huang, aHVhbmdjaGVuZ3poaTkzQGhvdG1haWwuY29t
†These authors have contributed equally to this work